Answers are grounded in this paper and cite their sources.
We suggest that clear and consistent information on prevalence, types, causes and contributory factors of medication discrepancy are required to develop suitable strategies to reduce the risk of adverse consequences on patient safety. Therefore, to obtain that information, we need a well-designed taxonomy to be able to accurately measure, report and classify medication discrepancies in clinical practice.
No takes yet. Share an insight, caveat, or question.
Almanasreh et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: